Spots Global Cancer Trial Database for A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application
Official Title: A New Efficient EBV AssociatedTechnologies of T Cells in Treating Malignant Tumors and Clinical Application
Study ID: NCT02980315
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to evaluate the safety of the designed LMP1-CAR -T cells and determine whether the CAR-T cells are effective in the treatment of EBV associated malignant tumors.
Detailed Description: Half of the patients will treat with LMP1-CAR-T cells,while the other half will receive a placebo.During the time of the treatment ,we will supervise the side effect of treated group.At last we compare the survival rate and health condition of the two groups.
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
SecondNanjingMU, Nanjing, Jiangsu, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
